- increased circulating cholesterol level / IMPC
- abnormal auditory brainstem response / IMPC
- increased mean corpuscular volume / IMPC
- decreased circulating unsaturated transferrin level / IMPC
- increased circulating HDL cholesterol level / IMPC
- increased grip strength / IMPC
- increased circulating iron level / IMPC
- abnormal retina blood vessel morphology / IMPC
- decreased locomotor activity / IMPC
C57BL/6N-Ldlrtm1a(EUCOMM)Wtsi/Ieg
Status | Available to order |
EMMA ID | EM:10076 |
International strain name | C57BL/6N-Ldlrtm1a(EUCOMM)Wtsi/Ieg |
Alternative name | EPD0437_2_F04 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Ldlrtm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Ldlr |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0437_2_F04. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | heterozygous C57BL/6NTac |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Homozygous familial hypercholesterolemia / Orphanet_391665
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- abnormal microglial cell morphology / MGI
- abnormal circulating cholesterol level / MGI
- abnormal circulating LDL cholesterol level / MGI
- increased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- abnormal triglyceride level / MGI
- alopecia / MGI
- abnormal liver physiology / MGI
- abnormal adrenal gland morphology / MGI
- abnormal hippocampus morphology / MGI
- abnormal CNS glial cell morphology / MGI
- scaly skin / MGI
- thick skin / MGI
- obese / MGI
- hyperactivity / MGI
- abnormal spatial learning / MGI
- increased circulating triglyceride level / MGI
- increased circulating free fatty acid level / MGI
- increased circulating HDL cholesterol level / MGI
- hyperglycemia / MGI
- liver inflammation / MGI
- abnormal glucose homeostasis / MGI
- increased circulating insulin level / MGI
- abnormal lipid homeostasis / MGI
- no abnormal phenotype detected / MGI
- abnormal astrocyte morphology / MGI
- hepatic steatosis / MGI
- decreased circulating triglyceride level / MGI
- decreased circulating corticosterone level / MGI
- gallstones / MGI
- increased circulating alanine transaminase level / MGI
- increased liver weight / MGI
- no phenotypic analysis / MGI
- retinal detachment / MGI
- amyloid beta deposits / MGI
- liver fibrosis / MGI
- oxidative stress / MGI
- maternal effect / MGI
- increased hepatocyte apoptosis / MGI
- abnormal circulating lipid level / MGI
- decreased lean body mass / MGI
- increased circulating VLDL triglyceride level / MGI
- increased cholesterol level / MGI
- abnormal arteriole morphology / MGI
- increased macrophage derived foam cell number / MGI
- increased circulating VLDL cholesterol level / MGI
- increased circulating cholesterol level / MGI
- decreased circulating cholesterol level / MGI
- abnormal retinal pigment epithelium morphology / MGI
- abnormal Bruch membrane morphology / MGI
- abnormal cholesterol homeostasis / MGI
- impaired glucose tolerance / MGI
- abnormal circulating amino acid level / MGI
- insulin resistance / MGI
- abnormal fat pad morphology / MGI
- atherosclerotic lesions / MGI
- increased susceptibility to atherosclerosis / MGI
- homeostasis/metabolism phenotype / MGI
- abnormal circulating protein level / MGI
- increased susceptibility to weight gain / MGI
- increased percent body fat/body weight / MGI
- increased circulating glucose level / MGI
- abnormal choriocapillaris morphology / MGI
- abnormal spatial working memory / MGI
- abnormal short term spatial reference memory / MGI
- increased circulating tumor necrosis factor level / MGI
- abnormal synaptic bouton morphology / MGI
- photoreceptor outer segment degeneration / MGI
- decreased circulating interleukin-10 level / MGI
- increased circulating interleukin-6 level / MGI
- increased circulating interleukin-1 beta level / MGI
- increased liver triglyceride level / MGI
- abnormal synapse morphology / MGI
- increased liver cholesterol level / MGI
- increased grip strength / MGI
- decreased susceptibility to weight gain / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).